Takeda Pharmaceutical Co Ltd
F:TKDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
F:TKDA
|
JP |
|
Establishment Labs Holdings Inc
F:3E0
|
CR |
|
J
|
JAFCO Group Co Ltd
DUS:JAF
|
JP |
Wall St Price Targets
TKDA Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKDA is 16.85 EUR with a low forecast of 13.93 EUR and a high forecast of 21.72 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKDA's stock price target?
Price Target
16.85
EUR
According to Wall Street analysts, the average 1-year price target for TKDA is 16.85 EUR with a low forecast of 13.93 EUR and a high forecast of 21.72 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
